Bookmark

Add to MyYahoo RSS

Theravance News

News on Theravance (Ticker: THRX) continually updated from thousands of sources around the net.

Monday Sep 8 | Freshnews

Theravance Biopharma Announces Positive Top-Line Results from Phase...

The study evaluated four doses of TD-4208 and placebo, administered once daily for 28 days in a double-blind, parallel group study in a total of 355 patients with moderate-to-severe COPD. TD-4208 met the primary efficacy endpoint at once-daily doses of 88, 175 and 350 mcg, with statistically significant changes versus placebo in trough FEV1 of 187 mL, 167 mL and 171 mL, respectively.

Comment?

Related Topix: Startups

Fri Sep 05, 2014

AmericanBankingNews.com

Theravance Sets New 12-Month Low at $20.43

Theravance shares reached a new 52-week low on Friday , American Banking & Market News reports. The company traded as low as $20.43 and last traded at $20.66, with a volume of 204,426 shares trading hands.

Comment?

Related Topix: Startups, Stanley

Thu Aug 21, 2014

Freshnews

Theravance Biopharma to Present at Investor Conferences in September 2014

Theravance Biopharma, Inc. announced today that Rick E Winningham, Theravance Biopharma's Chief Executive Officer, is scheduled to present at the following investor conferences in September 2014: Baird 2014 Health Care Conference The New York Palace, New York, New York Thursday, September 4, 2014 2:35 p.m. EDT The presentations will be webcast live ... (more)

Comment?

Related Topix: Startups

Seeking Alpha

Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market

Theravance is probably a familiar name to many of you. The pharmaceutical company has received extensive coverage on Seeking Alpha over the years.

Comment?

Related Topix: Startups, Copd, Medicine, Health, Biotech, GlaxoSmithKline, Healthcare Industry

Mon Aug 18, 2014

AmericanBankingNews.com

Theravance (THRX) Announces Quarterly Earnings Results, Beats Estimates By $0.35 EPS

Theravance posted its quarterly earnings results on Monday. The company reported earnings per share for the quarter, beating the consensus estimate of by $0.35, American Banking News.com reports.

Comment?

Related Topix: Startups, Stanley

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••